Matthew Williams, MD
Critical Care Medicine · Annandale, VANPI 1629084918
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $191,775 of the $235,053 with a category attached, or 81.6%. AstraZeneca accounts for 84.4% of it on its own, with 39 other manufacturers making up the rest. Among critical care medicine clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 666 payments — averaging $352.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$198K
- Genentech USA, Inc.$13K
- Amgen$10K
- Insmed, Inc.$6K
- GSK$3K
- Sanofi$747
- plus $4K from 34 others
What the payments were for
- Consulting fees$16,2337%
- Speaking & faculty fees$191,77582%
- Travel & lodging$11,5495%
- Food & beverage$15,2626%
- Education$2350%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 294 | $198,289 |
| Genentech USA, Inc. | 53 | $13,300 |
| Amgen | 37 | $9,773 |
| Insmed, Inc. | 28 | $6,370 |
| GSK | 59 | $2,804 |
| Sanofi | 34 | $747 |
| Regeneron Healthcare Solutions, Inc. | 19 | $616 |
| Boehringer Ingelheim | 24 | $464 |
| Mylan Specialty L.p. | 20 | $308 |
| Medtronic | 4 | $233 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $220 |
| Electromed, Inc. | 15 | $207 |
| Baxter Healthcare | 6 | $167 |
| Johnson & Johnson(2 entities) | 8 | $157 |
| TELA Bio, Inc. | 1 | $152 |
| Mallinckrodt Hospital Products Inc. | 5 | $148 |
| Gilead | 8 | $144 |
| Actelion Pharmaceuticals US, Inc. | 6 | $124 |
| Inari Medical, Inc. | 1 | $108 |
| United Therapeutics Corporation | 4 | $81 |
| Teva Pharmaceuticals USA, Inc. | 3 | $71 |
| Harmony Biosciences LLC | 2 | $55 |
| Novartis | 3 | $47 |
| Pulmonx Corporation | 2 | $47 |
| Sanofi-aventis U.S. LLC | 1 | $44 |
| Bayer | 2 | $40 |
| Philips North America LLC | 2 | $39 |
| Sanofi Pasteur Inc. | 2 | $39 |
| Astellas Pharma US Inc | 2 | $37 |
| Circassia Inc. | 2 | $31 |
| E.r. Squibb & Sons, L.L.C. | 2 | $26 |
| Grifols USA, LLC | 1 | $24 |
| Sunovion Pharmaceuticals Inc. | 1 | $24 |
| Inogen, Inc. | 1 | $22 |
| Vapotherm Inc | 1 | $19 |
| Verona Pharma, Inc. | 1 | $18 |
| Paratek Pharmaceuticals, Inc. | 1 | $17 |
| Shire North American Group Inc | 1 | $15 |
| Merck | 1 | $13 |
| Pfizer | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TEZSPIRE$102,777
- FASENRA$61,194
- AIRSUPRA$21,568
- XOLAIR$12,423
- Arikayce$2,035
- DUPIXENT$245
- OviTex Reinforced Bioscaffold With Permanent Polymer (OviTex)$152
- COREVALVE EVOLUT R$114
- FLOWTRIEVER CATHETER, S$108
- CT THROMBECTOMY SYSTEM KIT$108
- BREZTRI$105
How this compares
$235,053 in reported general payments places this provider in the 95th percentile of 174 critical care medicine providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OfevNintedanib Esylate | 53 | $567,151 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 311 | $378,303 |
| TezspireTezepelumab-Ekko | 56 | $241,752 |
| Dupixent PenDupilumab | 62 | $239,324 |
| Fasenra PenBenralizumab | 35 | $209,209 |
| ArikayceAmikacin Liposomal/Neb.Accessr | 12 | $174,701 |
| Spiriva RespimatTiotropium Bromide | 96 | $78,597 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 60 | $75,215 |
| Pirfenidone | 17 | $73,789 |
| Breo ElliptaFluticasone/Vilanterol | 105 | $71,699 |
| EliquisApixaban | 59 | $71,058 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 79 | $65,918 |
| Advair HfaFluticasone Propion/Salmeterol | 83 | $54,784 |
| XolairOmalizumab | 15 | $41,145 |
| Qvar RedihalerBeclomethasone Dipropionate | 65 | $34,551 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimOfev, Spiriva Respimat, Stiolto Respimat | $464 | $662,257169 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta, Incruse Ellipta, Arnuity Ellipta | $2,804 | $557,178576 claims |
| AstraZenecaTezspire, Breztri Aerosphere, Symbicort, Pulmicort Flexhaler | $198,289 | $346,192184 claims |
| Insmed, Inc.Arikayce | $6,370 | $174,70112 claims |
| PfizerEliquis | $12 | $71,05859 claims |
| Teva Pharmaceuticals USA, Inc.Qvar Redihaler | $71 | $34,55165 claims |
| Johnson & JohnsonXarelto | $157 | $30,30727 claims |
| MerckDulera | $13 | $15,58439 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 174 critical care medicine providers in Virginia.
Other critical care medicine in Annandale
- Ellen VaugheyAnnandale$6K
- Adlah SukkarAnnandale$4K
- Thieu DoAnnandale$842
- Oksana ShlobinFalls Church$375K
- Sami Abdul JawadFalls Church$193K
- Rajiv MalhotraRichmond$187K
- Thomas BouderWinchester$163K
- Christopher KingFalls Church$131K
- Rohit GoyalFredericksburg$95K
- Robert ThieleCharlottesville$52K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.